Trial Profile
RCT for the Treatment of Hemodialysis Catheter-Related Bacteremia
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II/III
Latest Information Update: 13 Oct 2015
Price :
$35
*
At a glance
- Drugs Tigecycline (Primary) ; Acetylcysteine; Heparin
- Indications Bacteraemia; Bacterial infections
- Focus Therapeutic Use
- Sponsors University of California, San Diego
- 07 Oct 2015 Status changed from not yet recruiting to withdrawn prior to enrolment, as reported by ClinicalTrials.gov.
- 24 Feb 2014 New trial record